Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Campus launch

26/10/2021
/ Webinar

IBA CAMPUS is the largest community sharing knowledge and experience in proton therapy.

This community is made up of technical, medical and business profiles.

...

PBT is a safe and feasible treatment for patients with second primary lung cancer after lung resection.

10/12/2018
/ Publications

A study from Japan reported 19 patients who were diagnosed with second primary lung cancer after lung resection, underwent PBT. This study reported the three...

Impact of unfavorable factors on outcomes among inoperable stage II-IV NSCLC patients treated with PT.

01/01/2019
/ Publications

A study by the Jacksonville group. 90 consecutive patients with unresectable stage II-IV (oligometastatic) NSCLC were treated with PT. Unfavorable factors...

Preliminary result of definitive radiotherapy in patients with NSCLC who have underlying idiopathic pulmonary fibrosis

01/01/2019
/ Publications
/
Survival

Idiopathic pulmonary fibrosis (IPF) is associated with fatal complications after radiotherapy (RT) for lung cancer patients. This study evaluated 264 patients...

Role of dose escalation and PT in perioperative or definitive treatment of chondrosarcoma and chordoma

01/01/2019
/ Publications
/
Survival

This study analyzed a total of 863 patients with chondrosarcoma and 715 patients with chordoma treated with proton or conventional radiation therapy. This study...

Is PT a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.

01/01/2019
/ Publications
/
Survival

With the national cancer database, a total of 724,492 patients were identified: 871 received PRT and 723,621 received non-PRT. The factors found to be...

Clinical IMPT for Hodgkin lymphoma: which patients benefit the most?

01/01/2019
/ Publications
/
Pencil Beam Scanning - PBS

21 HL patients treated with deep inspiration breath-hold pencil-beam scanning (PBS) PT. Normal tissue radiation doses were calculated and compared to doses from...

IMPT - The future of IMRT for head and neck cancer.

01/01/2019
/ Publications
/
IMRT
Dosimetry
Imaging System
Reirradiation

A review article looked at the development of RT advances. There is a growing awareness of the potential clinical benefits of proton therapy over IMRT in the...

Model-Based Approach to Predict ST Toxicity Benefits With PT for Oropharyngeal Cancer.

01/01/2019
/ Publications
/
Model-based approach

A study by UPenn and Groningen. For patients with advanced-stage oropharynx cancer treated with curative intent (PBT, n = 30; IMRT, n = 175), NTCP models were...

Increased Risk of Pseudoprogression among Pediatric Low-Grade Glioma Patients Treated with Proton vs Photon Radiotherapy.

01/01/2019
/ Publications
/
IMRT

Pseudoprogression (PsP) is a recognized phenomenon after radiotherapy (RT) for glioma. This study evaluated 83 pediatric low-grade glioma (LGG) patients treated...